Search

everythinglearnresearchcommunity

for

Search:↓

Adding hormone therapy to radiation improves survival for high-risk prostate cancer recurrence but has side effects.

DHL-HisZnNa may help reduce hair loss from chemotherapy, but more research is needed.

Genetic differences within ethnic groups may affect prostate cancer treatment effectiveness.

Kidney cancer cells without folliculin are more sensitive to radiation due to increased self-eating cell death.

A patient grew extra hair on their ears after treatment for testicular cancer, possibly due to hormonal changes or genetics.

The new drug carriers show promise for better targeting and treating ovarian cancer.

The COVID-19 pandemic led to fewer skin checks and skin cancer diagnoses in Australia in 2020.

Hair loss due to scalp metastasis from breast cancer, known as Neoplastic Alopecia, has a better survival rate than other scalp metastases and requires a biopsy for diagnosis.

5α-reductase inhibitors don't stop bladder cancer from developing or getting worse.

The lotion CG428 did not show effectiveness in treating permanent hair loss in breast cancer survivors.

Baldness, especially at the front, may lower the risk of testicular cancer by 31%, but its link to prostate cancer is unclear.

Using 5-alpha-reductase inhibitors may improve bladder cancer survival in men.

Men with a certain baldness pattern at age 40-50 may have a higher risk of aggressive prostate cancer.

Sex hormones might influence bladder cancer development, and aromatase inhibitors could increase risk in postmenopausal women.

The new chemotherapy combination for advanced lung cancer showed a 35.7% response rate but caused significant side effects.

Nanocarriers can improve the effectiveness of herbal medicines in treating colorectal cancer.

Agaricus bisporus derived β-Glucan could be an effective cervical cancer treatment with antimicrobial and antioxidant properties.

A prostate cancer drug can lower the levels of a protein that the coronavirus uses to enter lung cells.

Tongue cancer cells show more plectin-1 than non-cancer cells, but both have similar levels of trichohyalin.

Researchers found four natural compounds that can change DHT levels in prostate cancer cells.

Patients with advanced breast cancer and high hormone receptor levels who had surgery for ovarian/pelvic metastases lived longer, especially if they had high estrogen receptor levels.

Chemotherapy for prostate, bladder, and testicular cancer patients commonly causes hair loss, fatigue, and decreased appetite.

Plant-based compounds might be effective, low-side-effect treatments for prostate cancer by blocking a specific enzyme.

Finasteride is safe for hair loss treatment and doesn't increase high-grade prostate cancer risk.

Hair loss during breast cancer treatment affects each woman differently, influenced by her environment and family.

A cancer patient developed a type of hair loss after starting a cancer drug called vandetanib.

Early hair loss may increase the risk of prostate cancer, especially in African American men and those with frontal baldness.

Malignant melanoma is the deadliest skin cancer, while BCC is the most common but rarely spreads, and SCC is more aggressive than BCC.

Scientists at the University of Michigan Medical School successfully created a special compound that can be used to improve imaging of prostate cancer.

Male pattern baldness does not cause an increased risk of prostate cancer.